widely by region of the country, race, and socioeconomic factors. Decreasing rates of NC over the past 15 years are likely multifactorial, related to changing demographic trends and parental preference, but also indicative of access issues for patients with public insurance even after the 2011 AAP recommendations.
INTRODUCTION AND OBJECTIVES:
Minimally Invasive Surgery (MIS) has been gaining momentum in pediatric urology as a result of faster recovery, decreased post-operative pain, and improved cosmesis. In the era of quality outcomes, it is essential to analyze the unique complications in pediatric MIS. Given this context, we critically evaluated pediatric MIS complications in the published urologic literature.
METHODS: We searched the English medical literature using the key words "pediatric," "laparoscopic," "robotic," and surgery-specific terms (e.g. "nephrectomy"). We also consulted the references in articles, reviews, and meta-analyses for additional studies. Only studies with clear reporting of complications and open conversions were included. Post-operative complications were categorized using the Clavien-Dindo classification scheme (Grade I-II, IIIa-IIb, or IVþ). If a study did not use this classification, reported complications were categorized into Clavien-Dindo grades. Proportions were compared using the chi-square test.
RESULTS: A total of 169 articles were identified. Less than a fifth (18.9%) of the studies utilized the Clavien-Dindo classification system. The remaining studies (81.1%) did not use any standardized complication reporting, requiring categorization of complications to Clavien-Dindo grades. Table 1 shows the open conversion and complication rates of various MIS subdivided by technique. Notably, reconstructive operations had the highest rate of open conversions and complications while nephrectomies had the lowest rate of complications (Figure 1) .
CONCLUSIONS:
The rates of open conversions and complications vary by surgery in pediatric urologic MIS. Furthermore, despite the existence of a standardized complication classification system, a large majority of reviewed publications did not report complications in a standardized fashion. Our findings call for more robust studies in pediatric MIS and for universal implementation of standardized complication reporting in order to accurately assess the utilization of MIS in pediatric urology.
The Center for Disease Control (CDC) reports that over 40 people die each day from opioid overdose. The amount of opioid prescriptions written in the United States has quadrupled since 1999. These numbers are staggering and show an alarming dependency and abuse of prescription pain medication in the United States. In the midst of this opioid epidemic, the CDC recommends that opioids not be first line therapy and that prescribers weigh the risks and benefits to their patients when prescribing a narcotic. The goal of this study was to evaluate narcotic use in a pediatric population after urologic surgery.
METHODS: A short survey asking what medications were used after urologic surgery was given to family members of all patients to complete in private prior to a routine post-operative appointment. The survey asked if the patients received an opioid prescription, how many opioid doses were taken, and if the family had leftover medication. A retrospective review of the surveys was performed in addition to a retrospective chart review to collect basic demographic data including age at surgery, gender, and surgery type. Demographic factors were compared between patients who did and not use narcotics after surgery with t tests and Fisher's exact tests.
RESULTS: 634 patients were included with a mean age of 5 years old (SD 6.18) with 96% being male. 388 patients (61%) were prescribed narcotics and 342 (55%) used narcotics after surgery. Out of the 39% of the population that were not prescribed a narcotic, only 7 (3%) parents felt their child should have had a narcotic. Patients used a mean of 4 doses of narcotics (SD 4.84) and 319 patients (93%) had leftover narcotics. Factors significantly associated with narcotic use included age >3 and hypospadias surgery. Factors significantly associated with not using narcotics included age <3 and other penile and cystoscopic surgery, Table 1. CONCLUSIONS: We have been overprescribing narcotics after urologic surgery. Based on the survey data we recommend that narcotics are only prescribed for patients >3 years old unless the patient had a hypospadias repair. In cases when narcotics are indicated it appears only 5 doses is adequate. By obtaining and analyzing our data we are able to make better decisions if a narcotic is needed and to prescribe the lowest effective dosage with shorter duration of treatment. INTRODUCTION AND OBJECTIVES: MRI has been shown to increase detection of clinically significant cancer in the initial diagnosis of prostate cancer. We aim to investigate the ability of multiparametric MRI to detect Gleason Grade Group (GG) !2 cancer in a multiinstitutional active surveillance cohort with standardized follow up and biopsy protocols.
Source of
METHODS: Men enrolled in PASS across ten institutions were examined to identify men who underwent a biopsy within 12 months of a multiparametric MRI. Local interpretation of MRI PIRADS scores and biopsy GG were used in the analysis. MRI with no lesions or PIRADS 1-3 were considered negative and MRI with PIRADS 4-5 was considered positive. We investigate the performance MRI to detect GG2 or greater disease, controlling for the clinical factors of age, BMI, the proportion of positive cores, prostate size and PSA. We also compared GG found in systematic vs targeted cores in fusion biopsies.
RESULTS: We evaluated 351 MRIs from 325 individuals. The negative predictive value (NPV) of MRI for any GG2 or greater was 76% with a false positive rate of 49%. A negative MRI was significant in a multivariable logistic regression (OR 0.55, P[0.03) . In a sensitivity analysis of 287 MRI in 270 men with only GG1 cancer prior to MRI, biopsy reclassification to GG2 was observed in 27/127 (21%) of negative MRI and 49/139 (35%) of positive MRI. In this subset, negative MRI was not associated with reclassification to GG !2 in the multivariable model. In 192 fusion biopsies, GG concordance between the target and systematic biopsies was 81% (156/192). Targeted biopsies
